Strober, Bruce <br/><br/>
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.  [electronic resource] 

 -  International journal of dermatology  Apr 2016 
 - 401-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-4632 
<br/><br/><label>Standard No.: </label>10.1111/ijd.13236  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Male<br/>Middle Aged<br/>Pain--etiology<br/>Patient Reported Outcome Measures<br/>Pruritus--etiology<br/>Psoriasis--complications<br/>Severity of Illness Index<br/>Symptom Assessment